Panacea launches osteoarthritis drug
Panacea Biotec has launched Willgo (Nimesulide 200-mg long acting tablet), an advanced drug delivery system for 24-hour management of pain, inflammation and fever in osteoarthritis and post-surgical
Panacea Biotec has launched Willgo (Nimesulide 200-mg long acting tablet), an advanced drug delivery system for 24-hour management of pain, inflammation and fever in osteoarthritis and post-surgical